在严重喘中IL-18生物学
Sarita Thawanaphong1,2,3, Aswathi Nair1,2, Emily Volfson1,2
1Department of Medicine, McMAster University, Hamilton, ON, Canada.
Frontiers in medicine
|November 18, 2024
概括
介质素-18 (IL-18) 和炎症酶是严重喘的关键. 针对这些途径为慢性气道炎症和相关的自身免疫反应提供了一个有希望的新疗法.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 分子生物学分子生物学
背景情况:
- 慢性炎症性呼吸道疾病,如喘和COPD涉及复杂的免疫反应.
- 在这些条件下,越来越多地承认介质素-18 (IL-18) 和炎症体是关键的调解者.
- 了解IL-18的作用对于开发向疗法至关重要.
研究的目的:
- 在呼吸道疾病中审查IL-18和炎症体的生物学.
- 阐明IL-18在喘病理生理学中的特定参与,包括严重的病例.
- 为了确定IL-18和炎症体通路中的潜在治疗点.
主要方法:
- 文献综述综合了关于IL-18和炎症酶的当前研究.
- 分析IL-18在喘中的T2和非T2炎症中的作用.
- 探索IL-18对气道过敏反应和粘液生产的贡献.
主要成果:
- IL-18在严重的喘中起着重要作用,导致慢性炎症和气道过敏反应.
- IL-18与其他细胞因子相互作用,影响各种炎症途径.
- 新出现的证据将IL-18与呼吸道的自身免疫反应联系起来,特别是在感染患者中.
结论:
- IL-18是严重喘发病的一个关键因素.
- 准IL-18和炎症酶通路是严重喘的一种有前途的治疗策略.
- 对IL-18自身免疫连接的进一步研究可能会揭示新的治疗途径.
更多相关视频
09:00Characterization of Immune Cells and Proinflammatory Mediators in the Pulmonary Environment
Published on: June 24, 2020
3.3K
10:39Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
7.6K
相关概念视频
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
T Cell Types and Functions
954
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
954
Asthma: Pathogenesis and Management
359
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
359
Drugs Used in Lower Respiratory Disorders: Overview
353
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
353
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
237
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
237
